Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Grosset · SciRah

Researcher profile · Semantic Scholar

K. Grosset

Share profile

K. Grosset — researcher profile on SciRah

h-index: 31
Works: 88
Citations: 3,341

Most-cited papers

Suboptimal medication adherence in Parkinson's disease
K. Grosset, I. Bone, D. Grosset
2005Movement Disorders221 citations
Semantic Scholar
Neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies
Callum R. Smith, N. Malek, K. Grosset, B. Cullen +2 more
2019Journal of Neurology Neurosurgery & Psychiatry211 citations Open access
Semantic Scholar
Adherence to antiparkinson medication in a multicenter European study
D. Grosset, A. Antonini, M. Canesi, G. Pezzoli +14 more
2009Movement Disorders189 citations
Semantic Scholar
Problematic gambling on dopamine agonists: Not such a rarity
K. Grosset, G. Macphee, G. Pal, David Stewart +3 more
2006Movement Disorders174 citations
Semantic Scholar
Alpha‐synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease – a systematic review
N. Malek, D. Swallow, K. Grosset, O. Anichtchik +2 more
2014Acta Neurologica Scandinavica168 citations Open access
Semantic Scholar
Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
Michael T. Lawton, Y. Ben-Shlomo, M. May, F. Baig +14 more
2018Journal of Neurology Neurosurgery & Psychiatry167 citations Open access
Semantic Scholar
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
N. Malek, Michael A. Lawton, D. Swallow, K. Grosset +10 more
2016Movement Disorders161 citations Open access
Semantic Scholar
Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson’s Disease
M. Tan, Michael A. Lawton, E. Jabbari, R. Reynolds +24 more
2020medRxiv148 citations Open access
Semantic Scholar
Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
N. Malek, R. Weil, C. Bresner, Michael A. Lawton +12 more
2018Journal of Neurology Neurosurgery & Psychiatry132 citations Open access
Semantic Scholar
Patient‐perceived involvement and satisfaction in Parkinson's disease: Effect on therapy decisions and quality of life
K. Grosset, D. Grosset
2005Movement Disorders126 citations
Semantic Scholar
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table
K. Grosset, F. Needleman, G. Macphee, D. Grosset
2004Movement Disorders113 citations
Semantic Scholar
Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging
V. Marshall, J. Patterson, D. Hadley, K. Grosset +1 more
2006Nuclear medicine communications111 citations
Semantic Scholar
Medicine‐taking behavior: Implications of suboptimal compliance in Parkinson's disease
K. Grosset, John L. Reid, D. Grosset
2005Movement Disorders106 citations
Semantic Scholar
Genetic analysis of Mendelian mutations in a large UK population-based Parkinson’s disease study
M. Tan, N. Malek, Michael A. Lawton, Leon Hubbard +17 more
2019Brain : a journal of neurology76 citations Open access
Semantic Scholar
Tracking Parkinson’s: Study Design and Baseline Patient Data
N. Malek, D. Swallow, K. Grosset, Michael A. Lawton +13 more
2015Journal of Parkinson's Disease76 citations Open access
Semantic Scholar
Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trial
K. Grosset, D. Grosset
2007BMC Neurology72 citations Open access
Semantic Scholar
Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland
E. Newman, K. Breen, J. Patterson, D. Hadley +2 more
2009Movement Disorders70 citations
Semantic Scholar
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
Michael T. Lawton, Michele T. M. Hu, F. Baig, C. Ruffmann +14 more
2016Parkinsonism & Related Disorders68 citations Open access
Semantic Scholar
Measuring therapy adherence in Parkinson’s disease: a comparison of methods
K. Grosset, I. Bone, John L. Reid, D. Grosset
2006Journal of Neurology Neurosurgery & Psychiatry67 citations Open access
Semantic Scholar
Autonomic Dysfunction in Early Parkinson's Disease: Results from the United Kingdom Tracking Parkinson's Study
N. Malek, Michael A. Lawton, K. Grosset, N. Bajaj +9 more
2017Movement Disorders Clinical Practice59 citations Open access
Semantic Scholar
Parkinsonism and Related Disorders
Michael A. Lawton, F. Baig, C. Ruffmann, E. Barron +12 more
201656 citations
Semantic Scholar
Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
Nicholas Heng, N. Malek, Michael A. Lawton, A. Nodehi +4 more
2023Movement Disorders Clinical Practice54 citations Open access
Semantic Scholar
Phase IIa randomized double‐blind, placebo‐controlled study of inhaled apomorphine as acute challenge for rescuing ‘off’ periods in patients with established Parkinson's disease
K. Grosset, N. Malek, F. Morgan, D. Grosset
2013European Journal of Neurology45 citations
Semantic Scholar
Inhaled Apomorphine in Patients with ‘on-off’ Fluctuations: A Randomized, Double-blind, Placebo-controlled, Clinic and Home Based, Parallel-group Study
K. Grosset, N. Malek, F. Morgan, D. Grosset
2013Journal of Parkinson's Disease44 citations Open access
Semantic Scholar
Prescribed drugs and neurological complications
K. Grosset, D. Grosset
2004Journal of Neurology Neurosurgery & Psychiatry41 citations Open access
Semantic Scholar
Inhaled dry powder apomorphine (VR040) for ‘off ’ periods in Parkinson's disease: an in‐clinic double‐blind dose ranging study
K. Grosset, N. Malek, F. Morgan, D. Grosset
2013Acta Neurologica Scandinavica39 citations Open access
Semantic Scholar
Geographical difference in Parkinson's disease prevalence within West Scotland
E. Newman, K. Grosset, D. Grosset
2009Movement Disorders39 citations
Semantic Scholar
Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites
D. Davidson, K. Grosset, D. Grosset
2007Annals of Clinical Biochemistry37 citations Open access
Semantic Scholar
Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP‐CIT SPECT
V. Marshall, J. Patterson, D. Hadley, K. Grosset +1 more
2006Movement Disorders35 citations
Semantic Scholar
L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression.
N. Malek, S. Kanavou, Michael A. Lawton, Vanessa Pitz +11 more
2019Parkinsonism & Related Disorders34 citations Open access
Semantic Scholar
Variation in Recent Onset Parkinson’s Disease: Implications for Prodromal Detection
D. Swallow, Michael A. Lawton, K. Grosset, N. Malek +11 more
2016Journal of Parkinson's Disease32 citations Open access
Semantic Scholar
Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
D. Swallow, Michael A. Lawton, K. Grosset, N. Malek +13 more
2016Journal of Neurology Neurosurgery & Psychiatry29 citations Open access
Semantic Scholar
Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years
Sacha E. Gandhi, Tanja Zerenner, A. Nodehi, Michael A. Lawton +7 more
2024Movement Disorders Clinical Practice26 citations Open access
Semantic Scholar
Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients
N. Malek, D. Swallow, K. Grosset, Michael A. Lawton +11 more
2016Acta Neurologica Scandinavica26 citations Open access
Semantic Scholar
Combining biomarkers for prognostic modelling of Parkinson’s disease
N. Vijiaratnam, Michael A. Lawton, A. Heslegrave, Tong Guo +18 more
2022Journal of Neurology Neurosurgery & Psychiatry25 citations Open access
Semantic Scholar
Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease.
N. Malek, K. Grosset, David Stewart, G. Macphee +1 more
2013Parkinsonism & Related Disorders25 citations
Semantic Scholar
The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review
Vanessa Pitz, N. Malek, E. Tobias, K. Grosset +2 more
2020Movement Disorders Clinical Practice22 citations Open access
Semantic Scholar
Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
N. Malek, Michael A. Lawton, K. Grosset, N. Bajaj +9 more
2017Parkinsonism & Related Disorders21 citations Open access
Semantic Scholar
Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases.
D. Grosset, Elaine G Tyrrell, K. Grosset
2015Journal of Rehabilitation Medicine20 citations Open access
Semantic Scholar
Proposed dose equivalence for rapid switching between dopamine agonists in Parkinson's disease.
K. Grosset, D. Grosset
2006Clinical Therapeutics19 citations
Semantic Scholar
Genome-wide determinants of mortality and motor progression in Parkinson’s disease
Manuela M. X. Tan, M. Lawton, M. Pollard, E. Brown +36 more
2024npj Parkinson's Disease16 citations Open access
Semantic Scholar
Baseline [123I]FP‐CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease
T. Nissen, N. Malek, K. Grosset, E. Newman +3 more
2014Acta Neurologica Scandinavica16 citations Open access
Semantic Scholar
Factor structure of the Montreal Cognitive Assessment in Parkinson disease
Callum R. Smith, J. Cavanagh, M. Sheridan, K. Grosset +2 more
2019International Journal of Geriatric Psychiatry14 citations Open access
Semantic Scholar
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study
Callum R. Smith, B. Cullen, M. Sheridan, J. Cavanagh +2 more
2020Acta Neurologica Scandinavica13 citations Open access
Semantic Scholar
Parkinson's Disease: Clinican's Desk Reference
D. Grosset, H. Fernandez, K. Grosset, M. Okun
200913 citations
Semantic Scholar
Trial of subtherapeutic pergolide in de novo Parkinson's disease
K. Grosset, D. Grosset, A. Lees
2005Movement Disorders12 citations
Semantic Scholar
Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
Michael A. Lawton, M. Tan, Y. Ben-Shlomo, F. Baig +14 more
2022Journal of Neurology Neurosurgery & Psychiatry11 citations Open access
Semantic Scholar
Pergolide in Parkinson's disease: time for a change?
K. Grosset, D. Grosset
2004The Lancet11 citations Open access
Semantic Scholar
Comparison between four published definitions of hyposmia in Parkinson's disease
S. Kanavou, Vanessa Pitz, Michael A. Lawton, N. Malek +4 more
2021Brain and Behavior9 citations Open access
Semantic Scholar
Dopamine agonists and pathological gambling.
K. Grosset, G. Macphee, G. Pal, David Stewart +3 more
2007Parkinsonism & Related Disorders8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Grosset×50
Invite
D. Grosset — researcher profile on SciRah
N. Malek×26
Invite
N. Malek — researcher profile on SciRah
Michael A. Lawton×17
Invite
Michael A. Lawton — researcher profile on SciRah
Y. Ben-Shlomo×16
Invite
Y. Ben-Shlomo — researcher profile on SciRah

×13

Invite

R. Barker — researcher profile on SciRah

Invite

H. Morris — researcher profile on SciRah

Invite

N. Bajaj — researcher profile on SciRah

Invite

D. Burn — researcher profile on SciRah

Invite

N. Wood — researcher profile on SciRah

Invite

D. Swallow — researcher profile on SciRah

Invite

T. Foltynie — researcher profile on SciRah

Invite

N. Williams — researcher profile on SciRah